In conclusion, this study found that inhibition of ALK 4 and ALK 5 limited muscle wasting in a mouse model of cancer-associated cachexia and reduced the expression of cachexia associated ubiquitin ligase Atrogin-1. This evidence concerns the gene FBXO32 and Cachexia.